个人科研网厅 | | 帮助
首都医科大学宣武医院知识库
高级检索
当前位置： 首页 > 详情页

Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS

| 认领 | 导出 | |

文献详情

资源类型：

收录情况： ◇ SCIE

作者：
Zixiao Li[1,2,3,4] * ; Chunjuan Wang[2,3,4] * ; Yong Jiang[2,3,4] * ; Xinmiao Zhang[1,3,4] ; Ying Xian[5] ; Liping Liu[2,3,4,6] ; Xingquan Zhao[1,2,3,4] ; Hongqiu Gu[2,3,4] ; Xia Meng[2,3,4] ; Hao Li[2,3,4] ; Yilong Wang[1,2,3,4] ; Yongjun Wang [1,2,3,4] ;
机构： [1]Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [2]China National Clinical Research Center for Neurological Diseases, Beijing, China [3]Center of Stroke, Beijing Institute for BrainDisorders, Beijing, China [4]Beijing Key Laboratory of Translational Medicine forCerebrovascular Disease, Beijing, China [5]Duke Clinical Research Institute, North Carolina, USA [6]Neuro-intensive Care Unit, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
出处：
DOI： 10.1136/svn-2019-000233
ISSN：

关键词： acute ischemic stroke epidemiology mortality quality of care

摘要：
Background: In 2009, China launched ambitious healthcare reform plans to provide affordable and equitable basic healthcare for all patients, including the substantial number of patients who had a stroke. However, little is known about the pattern of evidence-based stroke care and outcomes across hospitals, regions and time during the last decade. Aims: The Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China (China PROGRESS) Study aims to use findings from a representative sample of Chinese hospitals over the last decade to improve future stroke care for patients hospitalised with ischaemic stroke (IS) or transient ischaemic attack (TIA). Design: The China PROGRESS Study will use a two-stage cluster sampling method to identify over 32000 patient records from 208 hospitals across the Eastern, Central and Western geographical regions in China. To assess the temporal trends in patient characteristics, treatment and outcomes, study investigators will select records from 2005, 2010 and 2015. A double data reading/entry system will be developed to conduct this assessment. A central coordinating centre will monitor case ascertainment, data abstraction and data management. Analyses will examine patient characteristics, testing patterns, in-hospital treatment and outcomes, and variations across regions and across time. Conclusions: The China PROGRESS Study is the first nationally representative study that aims to better understand care quality and outcomes for patients with IS or TIA before and after the national healthcare reform in China. This initiative will translate findings into clinical practices that improve care quality for patients who had a stroke and policy recommendations that allow these changes to be implemented widely. Ethics approval This study has also been approved by the central institutional review board (IRB) at Beijing Tiantan Hospital. © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

语种：
外文
中科院(CAS)分区：
出版当年[2018]版：
无
最新[2023]版：
大类 | 1 区 医学
小类 | 2 区 临床神经病学
JCR分区：
出版当年[2017]版：
无
最新[2023]版：
Q1 CLINICAL NEUROLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版]

第一作者：
第一作者机构： [1]Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [2]China National Clinical Research Center for Neurological Diseases, Beijing, China [3]Center of Stroke, Beijing Institute for BrainDisorders, Beijing, China [4]Beijing Key Laboratory of Translational Medicine forCerebrovascular Disease, Beijing, China
共同第一作者：
通讯作者：
通讯机构： [1]Vascular Neurology, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [2]China National Clinical Research Center for Neurological Diseases, Beijing, China [3]Center of Stroke, Beijing Institute for BrainDisorders, Beijing, China [4]Beijing Key Laboratory of Translational Medicine forCerebrovascular Disease, Beijing, China [*1]Vascular Neurology, Department of Neurology Beijing Tiantan Hospital, Capital Medical University Beijing China
推荐引用方式(GB/T 7714)：
Zixiao Li,Chunjuan Wang,Yong Jiang,et al.Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS[J].STROKE AND VASCULAR NEUROLOGY.2019,doi:10.1136/svn-2019-000233.
APA：
Zixiao Li,Chunjuan Wang,Yong Jiang,Xinmiao Zhang,Ying Xian...&Yongjun Wang.(2019).Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS.STROKE AND VASCULAR NEUROLOGY,,
MLA：
Zixiao Li,et al."Rationale and design of Patient-centered Retrospective Observation of Guideline-Recommended Execution for Stroke Sufferers in China: China PROGRESS".STROKE AND VASCULAR NEUROLOGY .(2019)

相关文献

[1]Rationale and design of a cluster-randomized multifaceted intervention trial to improve stroke care quality in China: The GOLDEN BRIDGE-Acute Ischemic Stroke [2]Correlation of hyperglycemia with mortality after acute ischemic stroke [3]Gastrointestinal Hemorrhage Is Associated with Mortality after Acute Ischemic Stroke. [4]Acute Effects of Particulate Air Pollution on Ischemic Stroke and Hemorrhagic Stroke Mortality [5]Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement [6]Gastrointestinal Hemorrhage is Associated with Mortality after Acute Ischemic Stroke [7]Prognostic role of hypochloremia in acute ischemic stroke patients [8]Prognostic Significance of Blood Urea Nitrogen in Acute Ischemic Stroke [9]2008年北京地区脑梗死住院患者医疗服务质量评价研究 [10]缺血性卒中医疗服务标准指标初步筛选结果分析

资源点击量：16399 今日访问量：0 总访问量：869 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持：重庆聚合科技有限公司 地址：北京市西城区长椿街45号宣武医院